CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project focuses on personalized cancer treatment by analyzing mutations in the p53 gene, which is commonly altered in tumors. It aims to develop tools that match treatments to specific p53 mutations, improving patient outcomes and reducing side effects.
Cancer is caused by a series of genetic alterations that confer an advantage to cancer cells, leading to uncontrolled growth.
However, each tumor exhibits distinct molecular changes, making each patient’s malignancy unique.
Hence, in the personalized medicine era, cancer treatment aims to tailor the most suitable treatment for each patient according to his/her genetic background, tumor acquired mutations and clinical indications.The p53 tumor suppressor is the most frequently mutated gene in hum…
WEIZMANN INSTITUTE OF SCIENCE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
